Cl ll Baxa Pharmacy compounding system

Company:Baxa Corp.
Date of Enforcement Report 4/18/12
Class ll:

PRODUCT
Pharmacy compounding system. It is a twenty-four source compounder for multi-source fluid mixing of both macro and micro ingredient down to 0.2 ml quantities. Product Usage: Pharmacy compounding System for parenteral macro and micro ingredients. 2 model numbers 2400 D and 2400 M. Recall # Z-1389-2012

REASON
Software issue with compounding pump resulting in over delivery of component ingredients during routine operations.

RECALLING FIRM/MANUFACTURER
Baxa Corp., Englewood, CO, by letter dated March 23, 2009. Firm iInitiated recall is ongoing.

VOLUME OF PRODUCT IN COMMERCE
1322 units

DISTRIBUTION
Nationwide and Canada

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

IEC 62304 and other Emerging Standards Impacting Medical Device Software

Being Agile & Yet Compliant

ISO 14971 SaMD Risk Management

Software Risk Management

Medical Device Cybersecurity

Software Verification

IEC 62366 Usability Process and Documentation

Or just email training@softwarecpr.com for more info.

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.